Skip to main content

States fight bonus pay for CEO of OxyContin maker Purdue

By Reuters  
   December 03, 2019

The chief executive officer of OxyContin-maker Purdue Pharma LP should not collect a potential $1.3 million bonus when he has been accused of contributing to the opioid epidemic, a group of state attorneys general said in a court filing on Monday.

Full story

Get the latest on healthcare leadership in your inbox.